Response Genetics, Inc (RGDXQ)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2015 | 48.88 Million USD | 263.58% |
| 2014 | 13.44 Million USD | -25.55% |
| 2013 | 18.05 Million USD | 8.86% |
| 2012 | 16.58 Million USD | 111.31% |
| 2011 | 7.85 Million USD | -25.95% |
| 2010 | 10.6 Million USD | -1.77% |
| 2009 | 10.79 Million USD | -20.34% |
| 2008 | 13.54 Million USD | -44.51% |
| 2007 | 24.41 Million USD | 195.58% |
| 2006 | 8.25 Million USD | 97.3% |
| 2005 | 4.18 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2015 FY | 48.88 Million USD | 263.58% |
| 2015 Q1 | 10.77 Million USD | -19.84% |
| 2014 FY | 13.44 Million USD | -25.55% |
| 2014 Q1 | 14.35 Million USD | -20.49% |
| 2014 Q2 | 12.22 Million USD | -14.87% |
| 2014 Q3 | 16.26 Million USD | 33.07% |
| 2014 Q4 | 13.44 Million USD | -17.34% |
| 2013 Q1 | 15.9 Million USD | -4.13% |
| 2013 Q4 | 18.05 Million USD | 20.41% |
| 2013 FY | 18.05 Million USD | 8.86% |
| 2013 Q2 | 15.06 Million USD | -5.25% |
| 2013 Q3 | 14.99 Million USD | -0.48% |
| 2012 Q4 | 16.58 Million USD | -3.33% |
| 2012 Q2 | 8.48 Million USD | -29.04% |
| 2012 Q1 | 11.95 Million USD | 52.23% |
| 2012 FY | 16.58 Million USD | 111.31% |
| 2012 Q3 | 17.16 Million USD | 102.35% |
| 2011 FY | 7.85 Million USD | -25.95% |
| 2011 Q4 | 7.85 Million USD | -17.38% |
| 2011 Q3 | 9.5 Million USD | -17.97% |
| 2011 Q2 | 11.58 Million USD | 21.72% |
| 2011 Q1 | 9.51 Million USD | -10.24% |
| 2010 FY | 10.6 Million USD | -1.77% |
| 2010 Q1 | 13.38 Million USD | 24.01% |
| 2010 Q2 | 12.5 Million USD | -6.56% |
| 2010 Q4 | 10.6 Million USD | -10.76% |
| 2010 Q3 | 11.87 Million USD | -5.01% |
| 2009 Q4 | 10.79 Million USD | -15.73% |
| 2009 FY | 10.79 Million USD | -20.34% |
| 2009 Q3 | 12.8 Million USD | 32.75% |
| 2009 Q2 | 9.64 Million USD | -25.76% |
| 2009 Q1 | 12.99 Million USD | -4.08% |
| 2008 Q1 | 22 Million USD | -9.88% |
| 2008 Q3 | 16.4 Million USD | -14.99% |
| 2008 Q4 | 13.54 Million USD | -17.39% |
| 2008 Q2 | 19.29 Million USD | -12.32% |
| 2008 FY | 13.54 Million USD | -44.51% |
| 2007 Q4 | 24.41 Million USD | 8.04% |
| 2007 Q2 | 24.71 Million USD | 196.62% |
| 2007 Q1 | 8.33 Million USD | 0.87% |
| 2007 FY | 24.41 Million USD | 195.58% |
| 2007 Q3 | 22.59 Million USD | -8.56% |
| 2006 FY | 8.25 Million USD | 97.3% |
| 2006 Q4 | 8.25 Million USD | 45.02% |
| 2006 Q3 | 5.69 Million USD | 0.0% |
| 2005 FY | 4.18 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Bio Medica Corporation | 1.26 Million USD | -3752.167% |
| Arrayit Corporation | 1 Million USD | -4786.499% |
| Atlantic International Corp. | 4.43 Million USD | -1001.894% |
| Biocept, Inc. | 30.87 Million USD | -58.339% |
| Bioqual, Inc. | 56.58 Million USD | 13.614% |
| CardioGenics Holdings Inc | 231.93 Thousand USD | -20976.867% |
| DermTech, Inc. | 121.93 Million USD | 59.908% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 4.18 Billion USD | 98.832% |
| HTG Molecular Diagnostics, Inc. | 17.77 Million USD | -174.974% |
| iMD Companies, Inc. | 190.13 Thousand USD | -25609.883% |
| IDenta Corp. | 1.52 Million USD | -3096.547% |
| Interpace Biosciences, Inc. | 13.02 Million USD | -275.424% |
| Integrative Health Technologies, Inc. | 8.25 Million USD | -492.396% |
| InVitro International | 1.53 Million USD | -3086.687% |
| Lumos Diagnostics Holdings Limited | 26.83 Million USD | -82.145% |
| Many Bright Ideas Technologies Inc. | 2312.00 USD | -2114259.862% |
| Medical Imaging Corp. | 4.19 Million USD | -1066.23% |
| NovelStem International Corp. | 2.25 Million USD | -2068.241% |
| Optigenex Inc. | 1.88 Million USD | -2488.797% |
| PharmChem, Inc. | 2.76 Million USD | -1667.599% |
| Proteome Sciences plc | 14.58 Million USD | -235.143% |
| Rennova Health, Inc. | 20.57 Million USD | -137.615% |
| RushNet, Inc. | 6.04 Million USD | -708.32% |
| ScreenPro Security Inc. | 1.26 Million USD | -3775.503% |
| Stella Diagnostics Inc. | 472.42 Thousand USD | -10247.506% |
| StageZero Life Sciences Ltd. | 700.65 Thousand USD | -6876.93% |
| Todos Medical Ltd. | 15.26 Million USD | -220.194% |